Stocks
Intra-Cellular Therapies (ITCI) Net margin US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -1 008% | -347.7% | -102.9% | -30.1% | -11.0% | -11.0% | ||
| Changes by years, y/y, % | +242 706pp | +660pp | +245pp | +73pp | +19pp | -86.5% | |||
Intra-Cellular Therapies. Net margin, %
Intra-Cellular Therapies. Net margin, changes, pp
Intra-Cellular Therapies (ITCI) Net margin US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| Net margin, % | ? | -21.7% | -10.5% | -10.1% | -15.0% | -8.48% | -11.0% | |
| Changes by years, y/y, % | +21pp | +36pp | +29pp | +4pp | +13pp | |||
| Changes by quarters, q/q, % | -2pp | +11pp | +0pp | -5pp | +7pp | |||
